Filing Details

Accession Number:
0001127602-19-028354
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-13 17:09:40
Reporting Period:
2019-09-12
Accepted Time:
2019-09-13 17:09:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1580827 C Eva Boratto One Cvs Drive
Woonsocket RI 02895
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-12 8,852 $54.53 55,273 No 4 M Direct
Common Stock Disposition 2019-09-12 8,130 $65.00 47,143 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-09-12 8,852 $0.00 8,852 $54.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-04-01 2020-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Restricted) 8,333 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 18,882 18,882 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 27,392 27,392 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 21,509 21,509 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 35,062 35,062 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 35,030 35,030 Direct
Common Stock Stock Option $54.19 2020-04-01 2029-04-01 202,007 202,007 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-01 18,882 18,882 Direct
2022-04-01 27,392 27,392 Direct
2023-04-01 21,509 21,509 Direct
2024-04-03 35,062 35,062 Direct
2025-04-01 35,030 35,030 Direct
2029-04-01 202,007 202,007 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.
  2. Option became exercisable in four equal annual installments, commencing 4/1/2014.
  3. Option became exercisable in four equal annual installments, commencing 4/1/2015.
  4. Option became exercisable in four equal annual installments, commencing 4/1/2016.
  5. Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
  6. Option became exercisable in four equal annual installments, commencing 4/3/2018.
  7. Option became exercisable in four equal annual installments, commencing 4/1/2019.
  8. Option becomes exercisable in four equal annual installments, commencing 4/1/2020.